EXPIRED
June 20, 2023
Companion Funding Opportunity
RFA-OD-23-050 , R21 Exploratory/Developmental Grants
RFA-OD-23-051 , R01 Research Project
National Institute on Drug Abuse (NIDA)
This notice corrects RFA-OD-23-051 RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional) to remove the emergency designation, extend the application due date, project period, and the review and award cycle dates.
Changes to the notice of funding opportunity (NOFO) are shown below:
Currently reads:
Title of funding opportunity:
Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
Key dates:
Application due dates: July 10, 2023
Review and award cycles:
Scientific Review Merit: August 2023
Advisory Council Review: Not Applicable
Earliest Start Date: September 2023
Expiration date: July 11, 2023
Section II. Award Information
Funds Available and Anticipated Number of Awards: The number of awards is contingent upon availability of funding and the submission of a sufficient number of meritorious applications. NIH estimates a commitment of the following amounts in FY 2024: $3,000,000-11,000,000, 1-4 awards. Awards may be multi-year funded.
Award Project Period: The maximum project period is three years.
Section IV. Application and Submission Information
6. Funding Restrictions: Awards issued under this NOFO may be incrementally funded awards for each budget period with a project period of 3 years . NIH will not issue any awards under this NOFO for a single budget period for multiple years. Project periods of greater than three years are not allowed.
Modified to Read (changes shown in bold italics):
Title of funding opportunity:
RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)
Key dates:
Application due dates: August 10, 2023
Review and award cycles:
Scientific Review Merit: January 2024
Advisory Council Review: May 2024
Earliest Start Date: June 2024
Expiration date: August 11, 2023
Section II. Award Information
Funds Available and Anticipated Number of Awards: The number of awards is contingent upon availability of funding and the submission of a sufficient number of meritorious applications. NIH estimates a commitment of the following amounts in FY 2024: $3,000,000-11,000,000, 1-4 awards.
Award Project Period: The maximum project period is four years.
Section IV. Application and Submission Information
6. Funding Restrictions:
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Ray Jacobson, PhD
Center of Scientific Review (CSR)
301-451-3409
jacobsonrh@csr.nih.gov